Suplementy diety w otylosci

• Autorzy: Respondek W. , Jarosz M.

Warianty tytułu

EN

Diet supplements in obesity

• Języki publikacji: PL

Słowa kluczowe

PL

choroby czlowieka; otylosc; zywienie czlowieka; dieta; suplementy diety; leczenie

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2004
• Tom: 31
• Numer: 4
• Opis fizyczny: s.353-362,bibliogr.

Twórcy

autor

Respondek W.

• Instytut Zywnosci i Zywienia w Warszawie, Warszawa

autor

Jarosz M.

Bibliografia

• 1. Anderson D. A., Wadden T. A.: Treating the obese patient suggestions for primary care practice. Arch. Fam. Med., 1999, 8, 156-167.
• 2. Szponar L., Sekuła W., Rychlik E., i wsp.: Badania indywidualnego spożycia żywności i stanu odżywienia w gospodarstwach domowych. Warszawa, Prace IZZ 101, 2003.
• 3. Moreno L. A., Tresaco B., Bueno G., et al.: Psyllium fibre and the metabolic control of obese children and adolescents. J. Physiol. Biochem., 2003, 59, 3, 235-242.
• 4. Rodriguez M. M., Guerrero R., Laczano B.: Lipid- and glucose lowering efficacy of plantago psyllium in II typr diabetes. J. Diabetes Complication, 1998, 12, 273-278.
• 5. Salguero M. O., Seijas R. C., Hernandez N. J., et al.: Esophageal obstruction caused by dietary fiber from Plantago ovata, a complication preventable by adequate information. Gastroenterol. Hepatol., 2003 26, 4, 248-250.
• 6. Schulz V.: Clinical trials with hypericum extracts in patients with depression - results, comparisons, conclusions for therapy with antidepressant drugs. Phytomedicine, 2002, 9, 5, 468-474.
• 7. Linde K., Ramirez G., Mulrow C. D., Pauls A.: St John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br. Med. J., 1996, 313, 253-258.
• 8. Turton-Weeks S. M., Barone G. W., Gurley B. J., et al.: St John's Wort: A Hidden Risk for Transplant Patients. Prog. Transplant., 2001, 11, 2, 116-120.
• 9. Scott G. N.: Update on natural product-drug interaction. Am. J. Health-Syst. Pharm., 2002, 59, 4, 339-347.
• 10. Suzuki O., Katsumata Y., Oya M.: Inhibition of monoamine oxidase by hypericin. Planta Med., 1984, 50, 272-274.
• 11. Shara M., Ohia S. E., Schmidt R. E., et al.: Physico-chemical properties of a novel (-)-hydroxycitric acid extract and its effect on body weight, selected organ weights, hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological changes over a period of 90 days. Mol. Cell. Biochem., 2004, 260,1-2, 171-86.
• 12. Rothacker D.Q., Waitman B. E.: Effectiveness of a Garcinia cambogia and natural caffeine combination in weight loss: a doubleblind placebo-controlled pilot study. Int. J. Obes., 1997, 21, Suppl 2, 53.
• 13. Heymsfield S. B., Allison D. B., Vasselli J. R., et al.: Garcinia cambogia (hydroxycitrie acid) as a potential antiobesity agent: a randomized controlled trial. J. Am. Med. Assoc., 1998, 280, 18, 1596-1600.
• 14. Mattes R. D., Bormann L.: Effects of (-)-hydroxycitric acid on appetitive variables. Physiol. Behav., 2000, 71, 1-2, 87-94.
• 15. Kovacs' E. M. R., Westerterp-Plantenga M. S., Vries M., et al.: Effects of 2-week ingestion of (-)-hydroxycitrate and (-)-hydroxycitrate combined with medium-chain triglycerides on satiety and food intake. Physiol. Behav., 2001, 74, 4-5, 543-549.
• 16. Food and Drug Administration. Center for Food Safety and Applied Nutrition. www.cfsan.fda.gov.
• 17. Preuss H.G., Di Ferdinando D., Bagchi M., Bagchi D.: Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. J. Med., 2002, 33, 1-4, 247-264.
• 18. Gershovich O. E., Lyman A. E.: Liver function test abnormalities and pruritis in a patient treated with atorvastatin: case report and review of the literature. Pharmacotherapy 2004, 24, 150-154.
• 19. Natural Medicines Comprehensive Database, 4 th Edition. Therapeutic Research Facility, 2002. http://chppm-www.apgea.army.mil/.
• 20. Cangiano C., Ceci F., Cascino A., et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am. J. Clin. Nutr., 1992, 56, 863-867.
• 21. InfoBase. www.wellfx.com.
• 22. Nicolodi M., Sicuteri F.: Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pa­thogenesis and therapy. Adv. Exp. Med. Biol., 1996, 398, 373-379.
• 23. Espinola E.B.: Pharmacological activity of Guarana in laboratory animals. J. Ethnopharmacol., 1997, 55, 223-229.
• 24. Herb and drug interaction, www.hillhealth.com.
• 25. Pittler M. H., Ernst E.: Guar gum for body weight reduction. Meta-analysis of randomized trials. Am. J. Med., 2001, 110, 724-730.
• 26. ASHP therapeutic position statement on the safe us of pharmacotherapy for obesity management in adults. Am. J. Health Syst. Pharm., 2001, 58, 17, 1645-1665.
• 27. Newall C. A., Anderson L. A., Phillipson J. D.: Herbal Medicines: A Guide for Health-Care Professionals. London, Pharmaceutical Press, 1996, 24-26.
• 28. Chantre P, Lairon D.: Recent findings of green tea extract AR25 and its activity for the treatment of obesity. Phytomedicine, 2002, 9, 1, 3-8.
• 29. Murray M. T.: The Healing Power of Herbs. Rocklin, CA Prima Publishing, 1995, 192-196.
• 30. Imai K., Nakachi K.: Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Br. Med. J., 1995, 310, 693-696.
• 31. Safetychecker Indexed by Herbal Remedy, www.kroger.com.
• 32. Boozer C. N, Nasser J.A., Heymsfield S. B., et al.: An herbal supplement containing Ma Huang- Guarana for weight loss: a randomized, double-blind trial. Int. J.Obes., 2001, 25, 3, 316-324.
• 33. Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products - Texas, December 1993-September 1995. MMWR Morb. Mortal Wkly. Rep., 1996, 45, 689-692.
• 34. Blumenthal M., Busse W. R., Goldberg A., et al.: The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, Integrative Medicine Communications, 1998, 204- 8.
• 35. Newall C.A., Anderson L. A., Phillipson J. D.: Herbal Medicines: A Guide for Healthcare Professionals. London, Pharmaceutical Press, 1996, 244.
• 36. Wang D. J., Chu K. M. , Chen J. D., et al.: Drug interaction between digoxin and bisacodyl. J. Formos. Med. Assoc., 1990, 89, 913, 915-9.
• 37. Mhurchu C. N., Poppitt S. D., McGill A. T., et al.: The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int. J. Obes. Relat. Metab. Disord., 2004, 28, 9, 1149-56.
• 38. Lengsfeld H., Fleury A., Nolte M., et al.: Effect of orlistat and chitosan on faecal fat excretion in young healthy volunteers. Obesity Research 1999, 7, 50S.
• 39. Pittler M. H., Ernst E.: Dietary supplements for body weight reduction: a systematic review. Am.J.Clin.Nutr., 2004, 79, 4, 529-536.
• 40. Hongu N. and Sachan D. S.: Carnitine and choline supplementation with exercise alter carnitine profiles, biochemical markers of fat metabolism and serum leptin concentration in healthy women. J. Nutr., 2003, 133, 84-89.
• 41. Khursheed N. J.: The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr. Rev., 1999, 57,11, 329-335.
• 42. De Flora S., Bagnasco M., Serra D., et al.: Genotoxicity of chromium compounds. A review. Mutat. Res., 1990, 238, 99-172.
• 43. Brown R.O., Forloines-Lynn S., Cross R. E., et. al.: Chromium deficiency after long-term total parenteral nutrition. Dig. Dis. Sei., 1986, 31,6, 661- 664.
• 44. Pittler M.H., Stevinson C., Ernst E.: Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Inter. J. Obes., 2003, 27, 4, 522- 529.
• 45. Juturu V, Komorowski J.R.: Chromium supplements, glucose and insuline response. Am. J. Clin. Nutr., 2003, 78, 1, 190-195.
• 46. Roberfroid M. B.:Functional foods: concepts and application to inulin and oligofructose. Br. J. Nutr., 2002, 87 Suppl. 2 S139-143.
• 47. Balcazar-Munoz B.R., Martinez-Abundis E., Gonzalez-Ortiz M.: Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev. Med. Chil., 2003, 131, 597-604.
• 48. Gibson G. R., Beatty E. R., Wang X., et al.: Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology, 1995, 108, 975-982.
• 49. Berning J. R.: Nutrition fir exercise and sport performance. In: Food, Nutrition and Diet Therapy. Ed. L.K. Mahan., S. Escott-Stump. USA, W.B. Saunders Company. 2000.
• 50. Kreider R.B.: Effects of creatine supplementation on performance and training adaptations. Mol. Cell. Biochem., 2003, 244, 1-2, 89-94.
• 51. Juhn M. S, O'Kane J. W, Vinci D. M.: Oral creatine supplementation in male collegiate athletes: a survey of dosing habits and side effects. J. Am. Diet. Assoc., 1999, 99, 593-595.
• 52. Food, Nutrition and Diet Therapy. Ed. L.K Mahan., S. Escott-Stump. USA,W.B. Saunders Company, 2000.
• 53. Pistone G., Marino A., Leotta C., et al.: Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Drugs Aging, 2003, 20, 10, 761-7.
• 54. Villani R.G.; Gannon J., Self M., Rich EA.: L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int. J. Sport Nutr. Exerc. Metab., 2000, 10, 2, 199-207.